Table 1.
Classification | Definition |
---|---|
Proven | • Positive C. burnetii in tissue or blood in absence of acute Q fever infection OR |
• IFA phase I IgG titer ≥1:1,024 with definite endocarditis according to the revised Duke criteria* OR | |
• IFA phase I IgG titer ≥1:1,024 with vascular infection diagnosed with PET/CT, CT, MRI or ultrasound testing | |
Probable | IFA phase I IgG titer ≥1:1,024 with one of the following manifestations: |
• Valvular deviation that does not meet the definition of endocarditis according to the Duke criteria | |
• Aneurysm, valvular- or vascular prosthesis without an infection on PET/CT, CT, MRI or ultrasound testing | |
• Suspicion of osteomyelitis or hepatitis as an expression of chronic Q fever | |
• Pregnancy | |
• Clinical symptoms of chronic infection (e.g. fever, weight loss, night sweating) | |
• Granulomatous infection | |
• Immunodeficiency | |
Possible | Solely a phase I IgG ≥1:1,024¥, without any of the manifestations mentioned in the categories proven and probable. |
*A set of clinical criteria for the diagnosis of infective endocarditis.
¥Phase I IgG antibody titer ≥1:1,024 is within the JBZ measured between 9 - 18 months after acute Q fever diagnosis.